Nafee Noha, Taetz Sebastian, Schneider Marc, Schaefer Ulrich F, Lehr Claus-Michael
Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany.
Nanomedicine. 2007 Sep;3(3):173-83. doi: 10.1016/j.nano.2007.03.006. Epub 2007 Aug 9.
Cationically modified poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles have recently been introduced as novel carriers for DNA/RNA delivery. The colloidal characteristics of the nanoparticles--particle size and surface charge--are considered the most significant determinants in the cellular uptake and trafficking of the nanoparticles. Therefore, our aim was to introduce chitosan-coated PLGA nanoparticles, whose size and charge are tunable to adapt for a specific task. The results showed that biodegradable nanoparticles as small as 130 nm and adjustable surface charge can be tailored controlling the process parameters. As a proof of concept, the overall potential of these particulate carriers to bind the antisense oligonucleotides, 2'-O-methyl-RNA, and improve their cellular uptake was demonstrated. The study proved the efficacy of chitosan-coated PLGA nanoparticles as a flexible and efficient delivery system for antisense oligonucleotides to lung cancer cells.
阳离子修饰的聚(D,L-丙交酯-共-乙交酯)(PLGA)纳米颗粒最近被引入作为DNA/RNA递送的新型载体。纳米颗粒的胶体特性——粒径和表面电荷——被认为是纳米颗粒细胞摄取和运输中最重要的决定因素。因此,我们的目标是引入壳聚糖包被的PLGA纳米颗粒,其大小和电荷可调以适应特定任务。结果表明,通过控制工艺参数,可以制备出小至130nm的可生物降解纳米颗粒并调节其表面电荷。作为概念验证,证明了这些颗粒载体结合反义寡核苷酸、2'-O-甲基-RNA并改善其细胞摄取的总体潜力。该研究证明了壳聚糖包被的PLGA纳米颗粒作为一种灵活高效的反义寡核苷酸递送系统用于肺癌细胞的有效性。